Amy R Rappaport

Amy R Rappaport

UNVERIFIED PROFILE

Are you Amy R Rappaport?   Register this Author

Register author
Amy R Rappaport

Amy R Rappaport

Publications by authors named "Amy R Rappaport"

Are you Amy R Rappaport?   Register this Author

10Publications

263Reads

21Profile Views

Direct and indirect targeting of MYC to treat acute myeloid leukemia.

Cancer Chemother Pharmacol 2015 Jul 9;76(1):35-46. Epub 2015 May 9.

Department of Laboratory Medicine and Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 513 Parnassus Avenue, Room S-561, Box 0451, San Francisco, CA, 94143-0451, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-015-2766-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485702PMC
July 2015

MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemia.

Cancer Cell 2014 May 1;25(5):652-65. Epub 2014 May 1.

Cancer Biology and Genetics Program, Memorial-Sloan Kettering Cancer Center, New York, NY 10065, USA; Howard Hughes Medical Institute, Memorial-Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccr.2014.03.016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4206212PMC
May 2014